Verastem (NASDAQ:VSTM) Research Coverage Started at Guggenheim
Guggenheim started coverage on shares of Verastem (NASDAQ:VSTM – Free Report) in a report issued on Monday, Marketbeat Ratings reports. The firm issued a buy rating and a $13.00 price target on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on VSTM. Truist Financial lowered their target price on […]
More Stories
HC Wainwright Lowers Shattuck Labs (NASDAQ:STTK) to Neutral
HC Wainwright lowered shares of Shattuck Labs (NASDAQ:STTK – Free Report) from a buy rating to a neutral rating in...
Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Tuesday morning....
ResMed (NYSE:RMD) Earns “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of ResMed (NYSE:RMD – Free Report) in a research report...
Rivian Automotive (NASDAQ:RIVN) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Rivian Automotive (NASDAQ:RIVN – Free Report) in a report released on...
Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note issued to investors on Tuesday...
Pinnacle Financial Partners (NASDAQ:PNFP) Rating Lowered to Equal Weight at Wells Fargo & Company
Wells Fargo & Company downgraded shares of Pinnacle Financial Partners (NASDAQ:PNFP – Free Report) from an overweight rating to an...